BRAIN Biotech AG introduces a controlled fermentation process combining commercial enzymes with microbial co-cultivation to optimize cocoa flavor and texture. This method ensures reproducible results, leveraging food-grade microorganisms and commercial enzyme preparations.
BRAIN Biotech AG presents an innovative approach to enhancing cocoa flavor and color through a controlled fermentation process. By integrating commercial enzymes with microbial co-cultivation, this method optimizes flavor and texture, offering a significant improvement over traditional fermentation techniques. The use of a variety of food-grade microorganisms, including yeasts, filamentous fungi, and bacteria, allows for tailored flavor profiles, resulting in a consistent and high-quality cocoa product.
Key features:
The process involves a systematic evaluation and screening matrix design, followed by the cultivation of microbial strains using this matrix. The results provide a generic and meaningful data set for developing specifically designed flavors.
This controlled fermentation technology is currently at Technology Readiness Level 3, indicating that it has been proven in a laboratory environment. The next steps involve material evaluation, microorganism and enzyme screening, followed by reproduction and scale-up to further validate and refine the process.
BRAIN Biotech AG is an integrated industrial biotechnology company that develops, produces, and distributes specialty enzymes, proteins, and microbial production strains. The company operates through two main business segments: BRAINBiocatalysts, which focuses on the commercialization of enzymes and specialty ingredients, and BRAINBioIncubator, which conducts research-intensive development projects. Utilizing advanced expertise in biology, bioinformatics, and bioprocess engineering, the company provides end-to-end services ranging from discovery and strain development to large-scale fermentation and manufacturing. They function as a partner for industries including food and beverage, life sciences, and chemical sectors, delivering solutions that aim to enhance industrial sustainability and efficiency.
By leveraging their proprietary technology portfolio and R&D capabilities, BRAIN Biotech enables customers to optimize production processes and develop more sustainable bio-based products. With over 30 years of experience, the company serves as an innovation partner that helps clients navigate complex development challenges, from laboratory-scale concepts to commercial-scale production. Their work directly addresses global sustainability goals by providing biological alternatives for traditional industrial methods. The group operates international facilities across Europe and the USA, providing a robust infrastructure to support long-term development partnerships and the monetization of biotechnological intellectual property.